Effective Ankaferd Hemostat Treatment For Severe Intractable Chronic Deep Leg Ulcer Associated With Behçet’s Disease
Rafiye ÇİFTÇİLER1, Erdinç ÇİFTÇİLER2, İbrahim HAZNEDAROĞLU1
1Department of Hematology, Hacettepe University Faculty of Medicine, Ankara, Turkey
2Department of General Surgery, Kızılcahamam State Hospital, Ankara, Turkey
Keywords: Ankaferd hemostat, Behçet’s disease, leg ulcer
Abstract
Ankaferd hemostat (Ankaferd Blood Stopper; ABS) is a pro-hemostatic agent affecting erythrocytes. In this article, we report a 50-year-old male patient who presented with a non-healing leg ulcer for one year. He had a past medical history of Behçet’s disease (BD) diagnosed at the age of 29 and therapy was started. Patient's leg ulcer did not respond to any treatment. Topical ABS was applied to the patient's leg ulcer daily. Our experience suggested that local treatment of ABS can be a potentially successful therapy for the management of intractable or incurable chronic ulcers in patients with BD or for other ischemic or vasculitic skin problems.
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
The authors received no financial support for the research and/or authorship of this article.